
Drugs Made In America Acquisition II Corp. - Right fell 66.3% from $0.15 to $0.05, behind the S&P 500's +7.1%. Its worst day was Jun 24 (−27.2%), and its low came Nov 6 at $0.05.
Dec 3, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Drugs Made In America Acquisition II Corp. - Right closed at its highest level of the year, 3.3% above where the year started.
+3.3% · S&P 500 +0.2%
Drugs Made In America Acquisition II Corp. - Right shares rose 28.0%, while the S&P 500 fell 0.3%.
Story events cover the past 12 months · Times ET
+28.0% · S&P 500 −0.3%
Drugs Made In America Acquisition II Corp. - Right shares fell 27.2%, while the S&P 500 fell 0.0%.
−27.2%, the year's worst day · S&P 500 0.0%
Drugs Made In America Acquisition II Corp. - Right shares rose 29.8%, while the S&P 500 fell 0.8%.
+29.8% · S&P 500 −0.8%
Drugs Made In America Acquisition II Corp. - Right shares rose 33.0%, while the S&P 500 rose 0.9%.
+33.0%, the year's best day · S&P 500 +0.9%
Drugs Made In America Acquisition II Corp. - Right shares rose 27.3%, while the S&P 500 fell 0.2%.
+27.3% · S&P 500 −0.2%
Where it ended: a close of $0.05 on Nov 10, 2026.
Nothing in the past 12 months.
All DMIIR earningsNothing in the past 12 months.
All DMIIR analyst actionsNothing in the past 12 months.
All DMIIR dividend historyNothing in the past 12 months.
All DMIIR news